XPC and melanoma: Survival analysis of melanomas with the lowest 10th percentile and highest 10th percentile XPC transcript expression in the TCGA melanoma dataset resulted in a similar trend towards poor survival in relation to low XPC transcript expression; TCGA 552.7 weeks for XPC+ compared to 221.1 weeks for XPC-, but it did not reach significance (p = 0.2).